Tamara Sussman is an Oncology physician. OpenAlex indexes 66 publications with 658 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Structural Racism, Reward Related Decision Making and Substance Use Risk
Sponsor: Columbia University
- Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
Sponsor: Dana-Farber Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck & Co.Program year20251 paymentResearch$960,380openpaymentsdata.cms.gov ↗
- AstraZenecaProgram year20231 paymentResearch$142,982openpaymentsdata.cms.gov ↗
- ARRAY BIOPHARMA INCProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Factors Associated with Delays in Initiation of Postoperative Radiotherapy (PORT) in Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics
2026 - Highly-Multiplex Detection of Plasma Cell-Free High-Risk Human Papillomavirus DNA for Rare Genotypes
Radiotherapy and Oncology
2026 - Incidence of Venous Thromboembolism Among Head and Neck Cancer Patients Receiving Chemotherapy: A Propensity-Matched Retrospective Cohort Analysis
International Journal of Radiation Oncology*Biology*Physics
2026 - Incidence and Impact of ctDNA Positivity in Cutaneous Squamous Cell Carcinoma
International Journal of Radiation Oncology*Biology*Physics
2026 - Ficerafusp Alfa 2000 mg Q2W Plus Pembrolizumab as First-Line (1L) Treatment for HPV-Negative Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
International Journal of Radiation Oncology*Biology*Physics
2026
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”